Asia-Pacific Americas Africa Europe Middle East

MORPEN LABORATORIES

Company Profile:

MORPEN LABORATORIES LTD. is a manufacturer (factory).

Company Introduction:

Morpen Laboratories Ltd. is a prominent Indian pharmaceutical company with a significant presence in both domestic and international markets. Established in 1988, the company is primarily involved in the manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), branded and generic finished dosage forms, and home healthcare products.

Key Highlights:

Manufacturing Capabilities: Morpen Laboratories operates modern, state-of-the-art manufacturing facilities that adhere to stringent international regulatory standards, including WHO-GMP, EU-GMP, and others. They possess dedicated production plants for both APIs and finished formulations.

Product Portfolio: Their diverse product range spans various therapeutic categories such as anti-infectives, cardiovascular, anti-diabetic, central nervous system, and pain management.

Research and Development: The company boasts a robust Research and Development infrastructure, continually focusing on the development of new molecules, process improvements, and pipeline expansion.

Global Presence: Morpen Laboratories exports its products to numerous countries worldwide, establishing itself as a trusted supplier in the global pharmaceutical industry.

Quality Assurance: The company is deeply committed to delivering high-quality, affordable pharmaceutical products to enhance global human health.

Enterprise Products

Morpen Laboratories Limited, an Indian pharmaceutical company, manufactures and sells a diverse range of products. These primarily fall into three main categories: Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations (Branded Generics), and Over-The-Counter (OTC) & Consumer Products.

Active Pharmaceutical Ingredients (APIs):

The company is a prominent manufacturer of various APIs, which are the key active components in medicines. These APIs are supplied to other pharmaceutical companies globally for the production of finished drugs. Key therapeutic segments for their APIs include:

Anti-infectives (e.g., Cefixime, Meropenem, Ciprofloxacin)

Cardiovascular drugs (e.g., Atorvastatin, Rosuvastatin, Telmisartan)

Anti-diabetic drugs (e.g., Metformin, Sitagliptin, Dapagliflozin)

Anti-inflammatory and Pain Management drugs (e.g., Ibuprofen, Paracetamol, Aceclofenac)

Gastrointestinal drugs (e.g., Pantoprazole, Esomeprazole, Ondansetron)

Respiratory drugs (e.g., Montelukast, Salbutamol)

Central Nervous System drugs (e.g., Pregabalin, Escitalopram)

Vitamins and Nutraceuticals (e.g., Folic Acid, Methylcobalamin)

Finished Dosage Formulations (Branded Generics):

Morpen Laboratories manufactures and markets a wide array of finished pharmaceutical products in various dosage forms such as tablets, capsules, syrups, and injections. These branded generic formulations address a broad spectrum of therapeutic areas, including:

Anti-infectives

Cardiovascular diseases

Anti-diabetic treatments

Pain management and Anti-inflammatory

Gastrointestinal disorders

Respiratory ailments

Central Nervous System disorders

Vitamins and Nutritional supplements

Anti-cold and cough remedies

Anti-allergics

Anti-malarials

Anti-fungals

Anti-ulcerants

Over-The-Counter (OTC) & Consumer Products:

The company also offers a range of OTC products directly to consumers for self-medication and general wellness. These typically include:

Pain relief balms and gels

Antacids

Cough and cold remedies

Vitamin and mineral supplements

Business Registration Information:

Manager:

Mr. Sushil Suri

Phone:

+91-11-23712952, 23712953, 23712954

E-mail:

info@morpen.com

Official Website:
Address:

409, 4th Floor, Antriksh Bhawan, 22, K.G. Marg, New Delhi - 110001, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.